Adam Pinney
Sports Medicine · Midland, MINPI 1639529290
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 71.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $4,719 and has fallen 98.8% since, to $56 in 2025.
Across 46 payments — averaging $111.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Medwest Associates$956
- Pacira Pharmaceuticals Incorporated$126
- Ferring Pharmaceuticals Inc.$107
- Johnson & Johnson$64
- Pacira Therapeutics, Inc.$44
- plus $153 from 8 others
What the payments were for
- Travel & lodging$1,64832%
- Food & beverage$1,06621%
- Education$2,40047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $3,665 |
| Medwest Associates | 5 | $956 |
| Pacira Pharmaceuticals Incorporated | 5 | $126 |
| Ferring Pharmaceuticals Inc. | 6 | $107 |
| Johnson & Johnson | 3 | $64 |
| Pacira Therapeutics, Inc. | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Amgen | 2 | $28 |
| Bioventus LLC | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Embody, Inc. | 1 | $16 |
| My01 Inc. | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $9 |
How this compares
$5,114 in reported general payments places this provider in the 75th percentile of 145 sports medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 406 | $2,750 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 27 | $2,560 |
| Meloxicam | 399 | $1,101 |
| Pregabalin | 62 | $885 |
| Diclofenac Sodium | 52 | $784 |
| Celecoxib | 36 | $420 |
| Methylprednisolone | 51 | $277 |
| Prednisone | 64 | $175 |
| Cyclobenzaprine Hcl | 59 | $135 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $94 |
| Methocarbamol | 15 | $93 |
| Naproxen | 21 | $41 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Midland
- Jack PinneyMidland$67K
- Richard GiannottiMidland$3K
- Tariq AwanFarmington Hills$113K
- Michael YusafAuburn Hills$101K
- William KestoNovi$62K
- Kendall HamiltonGrand Rapids$61K
- Carl WierksGrand Rapids$59K
- Manuel SchubertYpsilanti$42K
- Hussein SaadDearborn$40K
- Vasilios MoutzourosDetroit$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.